-
L Beltrame
Laboratory of Cancer Pharmacology, IRCCS Humanitas Research Hospital, Rozzano, Italy.
-
L Mannarino
Laboratory of Cancer Pharmacology, IRCCS Humanitas Research Hospital, Rozzano, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
-
A Sergi
Laboratory of Cancer Pharmacology, IRCCS Humanitas Research Hospital, Rozzano, Italy; Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
-
A Velle
Department of Biology, University of Padova, Padova, Italy.
-
I Treilleux
Biopathology Department, Centre Léon Bérard, Lyon, France.
-
S Pignata
Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Naples, Italy.
-
L Paracchini
Laboratory of Cancer Pharmacology, IRCCS Humanitas Research Hospital, Rozzano, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
-
P Harter
Department of Gynecology & Gynecologic Oncology, Evang. Kliniken Essen-Mitte, Essen, Germany.
-
G Scambia
Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.
-
F Perrone
Clinical Trial Unit, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Naples, Italy.
-
A González-Martin
Clínica Universidad de Navarra, Madrid, Spain; Spanish Ovarian Cancer Research Group (GEICO), Madrid, Spain.
-
R Berger
Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria; AGO Austria Study Center, Vienna, Austria.
-
L Arenare
Clinical Trial Unit, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Naples, Italy.
-
S Hietanen
Turku University Hospital, Turku, Finland; Nordic Society of Gynaecological Oncology (NSGO-CTU), Copenhagen, Denmark.
-
D Califano
Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Naples, Italy.
-
S Derio
Instituto Europeo di Oncologia, Milan, Italy; Mario Negri Gynecologic Oncology (MaNGO) Group, Milan, Italy.
-
T Van Gorp
University Hospital of Leuven, Leuven Cancer Institute, Leuven, Belgium; Belgium and Luxemburg Gynaecological Oncology Group (BGOG), Leuven, Belgium.
-
M L Dalessandro
Laboratory of Cancer Pharmacology, IRCCS Humanitas Research Hospital, Rozzano, Italy.
-
K Fujiwara
Saitama Medical University International Medical Center, Hidaka, Japan; Gynaecological Oncology Trial and Investigation Consortium (GOTIC), Saitama, Japan.
-
M Provansal
Institut Paoli Calmettes, Marseille, France; Groupe d'Investigateurs Nationaux Pour l'Etude des Cancers Ovariens (GINECO), Paris, France.
-
D Lorusso
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; Gynaecological Oncology Unit, Humanitas Hospital San Pio X, Milan, Italy.
-
P Buderath
Universitätsklinikum Essen, Frauenklinik, Essen, Germany.
-
M Masseroli
-
I Ray-Coquard
Groupe d'Investigateurs Nationaux Pour l'Etude des Cancers Ovariens (GINECO), Paris, France; Centre Léon Bérard, Lyon, France; University Claude Bernard Lyon I, Lyon, France.
-
E Pujade-Lauraine
ARCAGY Research, Paris, France.
-
C Romualdi
Department of Biology, University of Padova, Padova, Italy.
-
M D'Incalci
Laboratory of Cancer Pharmacology, IRCCS Humanitas Research Hospital, Rozzano, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy. Electronic address: maurizio.dincalci@hunimed.eu.
-
S Marchini
Laboratory of Cancer Pharmacology, IRCCS Humanitas Research Hospital, Rozzano, Italy.